Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study-Reference-Cited by-同舟云学术

Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study

Published:2021-10 Issue:10 Volume:6 Page:803-815
ISSN:2468-1253
Container-title:The Lancet Gastroenterology & Hepatology
language:en
Short-container-title:The Lancet Gastroenterology & Hepatology

Author:

Javle Milind,Roychowdhury Sameek,Kelley Robin Kate,Sadeghi Saeed,Macarulla Teresa,Weiss Karl Heinz,Waldschmidt Dirk-Thomas,Goyal Lipika,Borbath Ivan,El-Khoueiry Anthony,Borad Mitesh J,Yong Wei Peng,Philip Philip A,Bitzer Michael,Tanasanvimon Surbpong,Li Ai,Pande Amit,Soifer Harris S,Shepherd Stacie Peacock,Moran Susan,Zhu Andrew X,Bekaii-Saab Tanios S,Abou-Alfa Ghassan K

Funder

Novartis Pharmaceuticals Corp

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference32 articles.

1. Incidence of cholangiocarcinoma in the USA from 2001 to 2015: a US cancer statistics analysis of 50 states;Patel;Cureus,2019

2. Cholangiocarcinoma 2020: the next horizon in mechanisms and management;Banales;Nat Rev Gastroenterol Hepatol,2020

3. Epidemiology of cholangiocarcinoma; United States incidence and mortality trends;Gad;Clin Res Hepatol Gastroenterol,2020

4. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer;Valle;N Engl J Med,2010

5. Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial;Lamarca;Lancet Oncol,2021

Cited by 239 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cholangiocarcinoma;Treatment and Management of Tropical Liver Disease;2025

2. Racial and Sex Differences in Genomic Profiling of Intrahepatic Cholangiocarcinoma;Annals of Surgical Oncology;2024-09-09

3. Chinese national clinical practice guideline on diagnosis and treatment of biliary tract cancers;Chinese Medical Journal;2024-09-04

4. Tumor-associated macrophages: orchestrators of cholangiocarcinoma progression;Frontiers in Immunology;2024-09-03

5. Mitochondria targeted drug delivery system overcoming drug resistance in intrahepatic cholangiocarcinoma by reprogramming lipid metabolism;Biomaterials;2024-09